← FDA Drug Approvals (Drugs@FDA)

DATROWAY

BLA · Biologics License Application · Sponsor: DAIICHI SANKYO INC · Approved 2025-01-17

Drug application

FDA Application #

BLA761394

Application type

Biologics License Application

Brand name

DATROWAY

Generic name

DATOPOTAMAB DERUXTECAN

Active ingredients

DATOPOTAMAB DERUXTECAN-DLNK

Dosage form

INJECTABLE

Route

IV (INFUSION)

Marketing status

Prescription

Sponsor

DAIICHI SANKYO INC

Manufacturer

Daiichi Sankyo Inc.

First approval

2025-01-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown